Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L C Mulder

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The Journal of Biological Chemistry|July 14, 2000
Degradation of HIV-1 integrase by the N-end rule pathwayL C Mulder, M A Muesing
Gene|February 20, 1997
Human CD46 aberrant splicing in transgenic miceL C Mulder, M Rossini, M Mora
Immunology Today|December 1, 1996
Do macrophages kill through apoptosis?A O Aliprantis, G Diez-Roux, L C Mulder, et al.
Transplantation Proceedings|April 1, 1996
Human MCP and DHF double transgenic mice are protected from human complement attack in an in vivo modelL C Mulder, M Mora, M Lazzeri, et al.
Transplantation Proceedings|February 1, 1995
Mice transgenic for human CD46 and CD55 are protected from human complement attackL C Mulder, M Mora, E Ciccopiedi, et al.
The Journal of Urology|March 21, 1998
Kidneys derived from mice transgenic for human complement blockers are protected in an in vivo model of hyperacute rejectionM Lazzeri, M Mora, L C Mulder, et al.
Oncogene|January 10, 2002
Thymic hyperplasia and lung carcinomas in a line of mice transgenic for keratin 5-driven HPV16 E6/E7 oncogenesL Carraresi, S A Tripodi, L C Mulder, et al.
Genetic Analysis, Techniques and Applications|January 1, 1993
Preimplantation embryo sexing by polymerase chain reaction amplification of the sry gene on single mouse blastomeresL C Mulder, M G Sacco, L Mangiarini, et al.
Transplantation Proceedings|February 1, 1996
Characterization of complement-mediated liver damage and protection in control and transgenic mice for human complement blockers MCP and DAFL C Mulder, M Mora, M Lazzeri, et al.
Transgenic Research|October 14, 2000
An in vivo model of hyperacute rejection: characterization and evaluation of the effect of transgenic human complement inhibitorsM Mora, M Lazzer, G Marsicano, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Journal of Biological Chemistry|July 14, 2000
Degradation of HIV-1 integrase by the N-end rule pathwayL C Mulder, M A Muesing
Gene|February 20, 1997
Human CD46 aberrant splicing in transgenic miceL C Mulder, M Rossini, M Mora
Immunology Today|December 1, 1996
Do macrophages kill through apoptosis?A O Aliprantis, G Diez-Roux, L C Mulder, et al.
Transplantation Proceedings|April 1, 1996
Human MCP and DHF double transgenic mice are protected from human complement attack in an in vivo modelL C Mulder, M Mora, M Lazzeri, et al.
Transplantation Proceedings|February 1, 1995
Mice transgenic for human CD46 and CD55 are protected from human complement attackL C Mulder, M Mora, E Ciccopiedi, et al.
The Journal of Urology|March 21, 1998
Kidneys derived from mice transgenic for human complement blockers are protected in an in vivo model of hyperacute rejectionM Lazzeri, M Mora, L C Mulder, et al.
Oncogene|January 10, 2002
Thymic hyperplasia and lung carcinomas in a line of mice transgenic for keratin 5-driven HPV16 E6/E7 oncogenesL Carraresi, S A Tripodi, L C Mulder, et al.
Genetic Analysis, Techniques and Applications|January 1, 1993
Preimplantation embryo sexing by polymerase chain reaction amplification of the sry gene on single mouse blastomeresL C Mulder, M G Sacco, L Mangiarini, et al.
Transplantation Proceedings|February 1, 1996
Characterization of complement-mediated liver damage and protection in control and transgenic mice for human complement blockers MCP and DAFL C Mulder, M Mora, M Lazzeri, et al.
Transgenic Research|October 14, 2000
An in vivo model of hyperacute rejection: characterization and evaluation of the effect of transgenic human complement inhibitorsM Mora, M Lazzer, G Marsicano, et al.
Pageof 2